CICERI FABIO

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Decoding the Inflammasome Influence on Treatment Response in Acute Myeloid Leukemia

Not yet recruiting
Conditions
Interventions
First Posted Date
2024-08-02
Last Posted Date
2024-08-02
Lead Sponsor
Ciceri Fabio
Target Recruit Count
80
Registration Number
NCT06535113
Locations
🇮🇹

GOM Bianchi Melacrino Morelli, Reggio Calabria, Calabria, Italy

🇮🇹

IRCCS Ospedale San Raffaele, Milan, Italy

Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways

First Posted Date
2021-11-17
Last Posted Date
2022-07-21
Lead Sponsor
Ciceri Fabio
Target Recruit Count
500
Registration Number
NCT05124288
Locations
🇮🇹

IRCCS Ospedale San Raffaele, Milan, Milano, Italy

Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant

First Posted Date
2019-05-23
Last Posted Date
2023-11-18
Lead Sponsor
Ciceri Fabio
Target Recruit Count
15
Registration Number
NCT03961919
Locations
🇮🇹

Ospedale San Raffaele, Milano, Lombardia, Italy

© Copyright 2024. All Rights Reserved by MedPath